Category Archives: Uncategorized

Welcome to America’s opioid epidemic: where more people are hooked on prescription painkillers than tobacco

Two weeks ago, CNN released a great informative guide to American on drugs. After reaching out to every state for the latest statistics on drug deaths, they found that drug deaths continue to rise rapidly in many states, especially deaths due to overdoses. Drugs are now the leading cause of accidental death in this country, having […]

Read More

Posted in Uncategorized; Tagged: , , , , , .

When the Status Quo Feels like a Victory

This week Polish residents took to the streets. Dressed in black, they stood together in protest of a complete ban on access to abortion in their already conservative country. In Poland’s Communist era of the 1960s and 70s, abortions were easily available and cheap, with other European women even making the trip across the Iron […]

Read More

Posted in Health reform, Human Rights, Uncategorized;

No place to run: The forgotten vulnerabilities of the stateless

Co-written by Anna Roberts & Mehgan Gallagher The world is facing a significant humanitarian crisis around forced migration with millions fleeing their homes to escape violence, war and persecution. In parallel to the forced migration crisis is a significant, vulnerable and often overlooked group of individuals, those who are stateless. A stateless person is someone […]

Read More

Posted in Uncategorized;

O’Neill Institute Hosts Meeting to discuss improving Hepatitis C data collection and surveillance

On September 19th, the Hepatitis C Policy Project hosted a meeting at the Georgetown University Law Center in Washington, DC to discuss strategies to improve data collection and case surveillance for Hepatitis C in the United States. Thought leaders from a range of public health backgrounds, – including physicians, patient advocates, researchers and federal agency directors […]

Read More

Posted in National Healthcare, Uncategorized; Tagged: , .

The Exorbitant Pricing of Pharmaceuticals is in the News. Again.

This week the pharmaceutical pricing discussion centers on Mylan, and its 548% boost in the price of EpiPens. The press coverage and industry promises are a familiar scene: a large drug company buys a well-established medication or technology, and then raises the price. There is outrage, there are statements of promises and remedies, and then […]

Read More

Posted in FDA, Global Health, Uncategorized;


Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.